The primary genetic mutations identified in Dravet syndrome cases were SCN1A, followed by SCN2A and SCN9A. Within the cohort of four patients diagnosed with West syndrome, initially two patients responded to treatment, with a third patient showing a positive response in the subsequent interval. This evidence concerns the gene SCN2A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.